Citichem India to Review September Results on November 14

Citichem India Limited will review unaudited financial results for the quarter and half year ended September 30, 2026, on November 14, 2026, after its FY26 revenue from operations declined 49.3% to ₹9.48 crore. The board meeting is important because investors are awaiting updated financial data following a weaker FY26 top line.

When will Citichem India consider its September 2026 results?

Citichem India has scheduled a Board of Directors meeting for Saturday, November 14, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. The company informed BSE about the meeting on November 7, 2026.

The disclosure does not contain the September-quarter or half-year financial figures. Those details will be available after the board considers and approves the results at the scheduled meeting. The company has also stated that its trading window will remain closed until 48 hours after the financial results are declared.

What does the board meeting notice cover?

The notice covers approval of unaudited financial results for the period ended September 30, 2026. The company’s disclosures refer to the quarter ended September 30 as well as the quarter and half-year financial results, making the November 14 meeting the scheduled earnings event for Q2 FY27.

Citichem India’s most recent reported earnings event was the audited standalone financial results for the financial year ended March 31, 2026. Those results were approved by the board on May 30, 2026. Earlier, the company had reported unaudited financial results for the half year ended September 30, 2025, while its board had approved September 2024 half-year results on March 18, 2025.

The current announcement is an intimation of a forthcoming board meeting rather than a results outcome. It therefore does not disclose revenue, profit, margin, balance-sheet or cash-flow figures for the September 2026 period. Investors will need to rely on the formal outcome and financial statements released after the meeting for the latest operating assessment.

How did Citichem India perform in FY26?

Citichem India reported FY26 revenue from operations of ₹9.48 crore, down 49.3% from ₹18.70 crore in FY25. Total revenue fell 71.7% to ₹15.48 crore from ₹54.73 crore, according to the company’s audited standalone financial results for the year ended March 31, 2026.

Net profit for FY26 was ₹1.00 crore, compared with ₹1.23 crore in FY25, a decline of 18.5%. Profit before interest, depreciation and tax was ₹2.02 crore, marginally higher than ₹1.98 crore in the prior year. The figures indicate that profitability remained positive despite the sharp contraction in revenue.

What earlier half-year data provides context for the update?

Standalone data for the half year ended March 2026 showed net sales of ₹0.96 crore, down 88.73% from ₹8.52 crore in the half year ended September 2025. Net profit for the March 2026 half year was ₹0.32 crore, compared with ₹0.68 crore in the preceding half year.

However, operating profit before depreciation, interest and tax excluding other income was ₹0.78 crore in the March 2026 half year, up from ₹0.54 crore in September 2025. The corresponding operating margin excluding other income was 81.25%, compared with 6.34%. Interest expense was ₹0.32 crore, against ₹0.26 crore in the previous half year.

The FY26 results also showed total expenses of ₹13.46 crore, down 74.5% from ₹52.76 crore in FY25. The reduction in expenses was larger than the fall in total revenue on a percentage basis, which helps explain why the company retained a positive operating and net profit position despite lower sales.

What should investors monitor in the September results?

Investors will monitor whether Citichem India reports changes in revenue from operations, profitability and expenses for the September 2026 quarter and half year. FY26 saw a substantial decline in revenue, while net profit fell at a slower rate, making the relationship between sales and operating costs a key item in the forthcoming disclosure.

The September results will also provide the next reported financial update after the company’s FY26 audited numbers. Citichem India did not recommend a dividend for FY26 and transferred the year’s profit to the General Reserve, taking reserves and surplus to ₹14.30 crore. The company’s FY26 auditors, NGST & Associates, issued an unmodified opinion on the financial results.

For shareholders, the November 14 board meeting is a defined disclosure date rather than evidence of an operational outcome. The financial statements and board-meeting outcome will be required to assess the company’s latest performance and any reported change in its financial position.

Conclusion

Citichem India’s November 14 meeting will determine the release of unaudited results for the quarter and half year ended September 30, 2026. The update follows FY26, when revenue from operations declined to ₹9.48 crore and net profit stood at ₹1.00 crore, while operating profitability remained positive.

The next item to watch is the board’s formal outcome on November 14 and the accompanying financial statements. Investors can then compare the September 2026 revenue, profit, expenses and margins with the FY26 and prior half-year figures already disclosed by the company.